-
Product Insights
New![]()
GM Sugars Cogeneration Power Plant
GM Sugars Cogeneration Power Plant is a biopower project located in Karnataka, India. The project is owned and being developed by GM Sugars and Energy Ltd. The project is at the permitting stage. Empower your strategies with our GM Sugars Cogeneration Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Company Insights
New![]()
Innovation and Patenting activity of GMS Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GMS Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Depression Drug Details: GM-2505 is under development for the treatment of depression and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-1020 in Depression
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GM-1020 in Depression Drug Details: GM-1020 is under development for the treatment of depression and opiate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Psychiatric Disorders
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Psychiatric Disorders Drug Details: GM-2505 is under development for the treatment of depression...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-101 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-101 in Solid Tumor Drug Details: GM-101 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-6 in Acute Ischemic Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GM-6 in Acute Ischemic Stroke Drug Details:GM-6 is under development for the treatment of amyotrophic lateral...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-1020 in Major Depressive Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GM-1020 in Major Depressive Disorder Drug Details: GM-1020 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GM-60106 in Non-Alcoholic Steatohepatitis (NASH)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GM-60106 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:GM-60106 is under development for the treatment of non-alcoholic steatohepatitis (NASH)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RNX-21 in Venous Leg Ulcers (Crural Ulcer)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.RNX-21 in Venous Leg Ulcers (Crural Ulcer)Drug Details:Molgramostim (RNX-21) is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.